Shentu vs Enzyme — how do they compare? Shentu trades at Rp1,830 (market cap Rp296,94M, Rp21,91M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Shentu is far larger — about 2.2× Enzyme's market cap, and Shentu's circulating supply is 162,6M CTK versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold Shentu for 44 Days and Enzyme for 29 Days on average.
| CTK | MLN | |
|---|---|---|
Market Cap | Rp296,94M | Rp134,13M |
Volume (24h) | Rp21,91M | Rp104,56M |
Circulating Supply | 162,6M CTK | 3,3M MLN |
Typical Hold Time | 44 Days | 29 Days |
Signals from Pluang's Aura AI — not financial advice
Shentu (CTK) is trading at Rp1,849 with a market cap of Rp301.81 million, showing a bullish overall signal driven by oscillators, while moving averages indicate bearish pressure. Key technical levels place support at Rp1,811 and resistance at Rp1,950. The token's 44-day average hold time suggests moderate holding behavior among investors. No major protocol updates or ecosystem news were noted recently, keeping fundamental developments quiet.
Outlook: CTK presents a cautious buy opportunity with bullish momentum but faces resistance near Rp1,950. Risks include low liquidity and crypto market volatility. Investors should monitor volume trends and regulatory shifts in the Indonesian crypto space, as thin trading could amplify price swings.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Latest headlines on both assets
Shentu Chain, a security-first, delegated proof-of-stake blockchain, for trustworthy execution of mission-critical applications, including DeFi, NFTs, and autonomous vehicles. Shentu Chain prioritizes cross-chain compatibility, built as a Cosmos Hub with full EVM and Hyperledger Burrow compatibility, as well as compatibility with eWASM and Ant Financial’s AntChain.
Read more on CTK →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →